Vimarsana
Biggest News Aggregation in the World

Page 7 - Acids Res News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acids Res. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acids Res Today - Breaking & Trending Today

The complementarity of DDR, nucleic acids and anti-tumour immunity - Vimarsana News

The complementarity of DDR, nucleic acids and anti-tumour immunity

Immune checkpoint blockade (ICB) immunotherapy is a first-line treatment for selected cancers, yet the mechanisms of its efficacy remain incompletely understood. Furthermore, only a minority of patients with cancer benefit from ICB, and there is a lack of fully informative treatment response biomarkers. Selectively exploiting defects in DNA damage repair is also a standard treatment for cancer, spurred by enhanced understanding of the DNA damage response (DDR). DDR and ICB are closely linked—faulty DDR produces immunogenic cancer neoantigens that can increase the efficacy of ICB...

Source: nature.com
Cooperation between bHLH transcription factors and histones for DNA access - Vimarsana News

Cooperation between bHLH transcription factors and histones for DNA access

The basic helix–loop–helix (bHLH) family of transcription factors recognizes DNA motifs known as E-boxes (CANNTG) and includes 108 members1. Here we investigate how chromatinized E-boxes are engaged by two structurally diverse bHLH proteins: the proto-oncogene MYC-MAX and the circadian transcription factor CLOCK-BMAL1 (refs. 2,3). Both transcription factors bind to E-boxes preferentially near the nucleosomal entry–exit sites. Structural studies with engineered or native nucleosome sequences show that MYC-MAX or CLOCK-BMAL1 triggers the release of DNA from histones to gain acc...

Source: nature.com
Therapy-induced APOBEC3A drives evolution of persistent cancer cells - Vimarsana News

Therapy-induced APOBEC3A drives evolution of persistent cancer cells

Acquired drug resistance to anticancer targeted therapies remains an unsolved clinical problem. Although many drivers of acquired drug resistance have been identified1–4, the underlying molecular mechanisms shaping tumour evolution during treatment are incompletely understood. Genomic profiling of patient tumours has implicated apolipoprotein B messenger RNA editing catalytic polypeptide-like (APOBEC) cytidine deaminases in tumour evolution; however, their role during therapy and the development of acquired drug resistance is undefined. Here we report that lung cancer targeted ther...

Source: nature.com
From fossils to mind | Communications Biology - Vimarsana News

From fossils to mind | Communications Biology

Fossil endocasts record features of brains from the past: size, shape, vasculature, and gyrification. These data, alongside experimental and comparative evidence, are needed to resolve questions about brain energetics, cognitive specializations, and developmental plasticity. Through the application of interdisciplinary techniques to the fossil record, paleoneurology has been leading major innovations. Neuroimaging is shedding light on fossil brain organization and behaviors. Inferences about the development and physiology of the brains of extinct species can be experimentally investigated thro...

Source: nature.com
Structure and function of the RAD51B–RAD51C–RAD51D–XRCC2 tumour suppressor - Vimarsana News

Structure and function of the RAD51B–RAD51C–RAD51D–XRCC2 tumour suppressor

Homologous recombination is a fundamental process of life. It is required for the protection and restart of broken replication forks, the repair of chromosome breaks and the exchange of genetic material during meiosis. Individuals with mutations in key recombination genes, such as BRCA2 (also known as FANCD1), or the RAD51 paralogues RAD51B, RAD51C (also known as FANCO), RAD51D, XRCC2 (also known as FANCU) and XRCC3, are predisposed to breast, ovarian and prostate cancers1–10 and the cancer-prone syndrome Fanconi anaemia11–13. The BRCA2 tumour suppressor protein—the ...

Source: nature.com